Bridgecreek Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $25.2M | Sell |
45,490
-2,050
| -4% | -$962K | 4.89% | 4 |
|
|
2023
Q3 | $20.8M | Sell |
47,540
-1,775
| -4% | -$885K | 4.25% | 5 |
|
|
2023
Q2 | $24.8M | Sell |
49,315
-1,250
| -2% | -$599K | 4.74% | 5 |
|
|
2023
Q1 | $25.3M | Sell |
50,565
-430
| -0.8% | -$206K | 5.21% | 3 |
|
|
2022
Q4 | $20.8M | Sell |
50,995
-2,300
| -4% | -$893K | 4.64% | 3 |
|
|
2022
Q3 | $17.4M | Sell |
53,295
-150
| -0.3% | -$55.1K | 3.71% | 5 |
|
|
2022
Q2 | $18.7M | Sell |
53,445
-110
| -0.2% | -$44.9K | 3.89% | 5 |
|
|
2022
Q1 | $29.3M | Sell |
53,555
-910
| -2% | -$479K | 4.34% | 5 |
|
|
2021
Q4 | $35.9M | Sell |
54,465
-325
| -0.6% | -$204K | 4.9% | 5 |
|
|
2021
Q3 | $34.1M | Sell |
54,790
-540
| -1% | -$363K | 4.87% | 4 |
|
|
2021
Q2 | $34.9M | Sell |
55,330
-3,450
| -6% | -$1.91M | 5.08% | 3 |
|
|
2021
Q1 | $28.8M | Buy |
58,780
+2,350
| +4% | +$1.18M | 4.45% | 4 |
|
|
2020
Q4 | $28.2M | Sell |
56,430
-3,210
| -5% | -$1.44M | 4.28% | 4 |
|
|
2020
Q3 | $23.4M | Sell |
59,640
-290
| -0.5% | -$107K | 4.12% | 5 |
|
|
2020
Q2 | $19.8M | Sell |
59,930
-150
| -0.2% | -$43.4K | 3.7% | 6 |
|
|
2020
Q1 | $14.6M | Sell |
60,080
-2,315
| -4% | -$604K | 3.77% | 8 |
|
|
2019
Q4 | $16.3M | Sell |
62,395
-645
| -1% | -$170K | 2.96% | 5 |
|
|
2019
Q3 | $17.1M | Sell |
63,040
-25
| -0% | -$6.96K | 3.56% | 4 |
|
|
2019
Q2 | $17.4M | Sell |
63,065
-1,205
| -2% | -$297K | 3.63% | 3 |
|
|
2019
Q1 | $14.4M | Sell |
64,270
-1,250
| -2% | -$258K | 3.05% | 7 |
|
|
2018
Q4 | $12.2M | Sell |
65,520
-10
| -0% | -$2.05K | 3.25% | 6 |
|
|
2018
Q3 | $16.4M | Sell |
65,530
-135
| -0.2% | -$32.8K | 3.26% | 6 |
|
|
2018
Q2 | $14.3M | Buy |
65,665
+75
| +0.1% | +$15.5K | 3.12% | 6 |
|
|
2018
Q1 | $12.6M | Sell |
65,590
-500
| -0.8% | -$92.3K | 2.83% | 6 |
|
|
2017
Q4 | $10.3M | Buy |
66,090
+6,405
| +11% | +$1.01M | 2.43% | 7 |
|
|
2017
Q3 | $9.28M | Sell |
59,685
-455
| -0.8% | -$71.9K | 2.52% | 7 |
|
|
2017
Q2 | $9.71M | Sell |
60,140
-325
| -0.5% | -$52.8K | 2.59% | 6 |
|
|
2017
Q1 | $9.35M | Sell |
60,465
-5,655
| -9% | -$780K | 2.54% | 3 |
|
|
2016
Q4 | $7.75M | Sell |
66,120
-7,095
| -10% | -$810K | 2.19% | 5 |
|
|
2016
Q3 | $8.25M | Sell |
73,215
-10,535
| -13% | -$1.11M | 2.47% | 6 |
|
|
2016
Q2 | $7.78M | Sell |
83,750
-1,930
| -2% | -$166K | 2.39% | 7 |
|
|
2016
Q1 | $6.71M | Sell |
85,680
-4,235
| -5% | -$305K | 2.16% | 15 |
|
|
2015
Q4 | $6.56M | Sell |
89,915
-323
| -0.4% | -$23K | 2.08% | 14 |
|
|
2015
Q3 | $6.7M | Sell |
90,238
-380
| -0.4% | -$27.2K | 2% | 12 |
|
|
2015
Q2 | $5.81M | Sell |
90,618
-8,500
| -9% | -$588K | 1.46% | 25 |
|
|
2015
Q1 | $7.66M | Sell |
99,118
-10,192
| -9% | -$793K | 1.8% | 9 |
|
|
2014
Q4 | $8.1M | Buy |
109,310
+2,140
| +2% | +$150K | 2.12% | 7 |
|
|
2014
Q3 | $6.31M | Sell |
107,170
-80
| -0.1% | -$5.06K | 1.7% | 23 |
|
|
2014
Q2 | $7.16M | Buy |
107,250
+4,960
| +5% | +$315K | 1.9% | 14 |
|
|
2014
Q1 | $6.21M | Buy |
102,290
+1,710
| +2% | +$102K | 1.8% | 17 |
|
|
2013
Q4 | $5.35M | Buy |
100,580
+520
| +0.5% | +$27.4K | 1.63% | 27 |
|
|
2013
Q3 | $4.99M | Buy |
100,060
+1,040
| +1% | +$50K | 1.47% | 32 |
|
|
2013
Q2 | $4.44M | Buy |
+99,020
| New | +$4.33M | 1.51% | 30 |
|
Other funds holding IDXX
Bridgecreek Investment Management's IDXX Position: Q4 2023 in Review
Bridgecreek Investment Management reduced its Idexx Laboratories (IDXX) stake by 4.3% in Q4 2023, selling an estimated $962K and leaving 45,490 shares worth $25.2M. The position accounts for 4.89% of the portfolio, ranked #4.
Bridgecreek Investment Management first reported a position in IDXX in Q2 2013 and has held it in 43 quarters since. The position peaked at $35.9M in Q4 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.
- Bridgecreek Investment Management held 45,490 shares of Idexx Laboratories worth $25.2M as of Q4 2023.
- Bridgecreek Investment Management sold 2,050 Idexx Laboratories shares in Q4 2023, an estimated $962K.
- Idexx Laboratories made up 4.89% of Bridgecreek Investment Management's portfolio in Q4 2023, its #4 holding.
- Bridgecreek Investment Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 43 quarters since.
- Bridgecreek Investment Management's Idexx Laboratories position peaked at $35.9M in Q4 2021.
- 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.
Based on Bridgecreek Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.